The University of Chicago Header Logo

Is it time to use minimal residual disease to stratify post-remission treatment for acute myeloid leukemia?

Is it time to use minimal residual disease to stratify post-remission treatment for acute myeloid leukemia? Leuk Lymphoma. 2015; 56(11):3005-7.

View in: PubMed